US 11529390
PCSK9 inhibitory polypolypeptides and methods of use
granted A61KA61K38/16A61K38/55
Quick answer
US patent 11529390 (PCSK9 inhibitory polypolypeptides and methods of use) held by INSTITUT DE CARDIOLOGIE DE MONTREAL expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INSTITUT DE CARDIOLOGIE DE MONTREAL
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/16, A61K38/55, A61K47/6937